Drägerwerk AG & Co. KGaA (0MT8.L)
EUR 41.3
(-2.59%)
EUR 41.3
(-2.59%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.84 Billion EUR | 3.36% |
| 2022 | 1.78 Billion EUR | -6.81% |
| 2021 | 1.91 Billion EUR | -15.6% |
| 2020 | 2.27 Billion EUR | 52.03% |
| 2019 | 1.49 Billion EUR | 12.41% |
| 2018 | 1.32 Billion EUR | 3.39% |
| 2017 | 1.28 Billion EUR | -1.74% |
| 2016 | 1.3 Billion EUR | -4.15% |
| 2015 | 1.36 Billion EUR | 2.09% |
| 2014 | 1.33 Billion EUR | 7.08% |
| 2013 | 1.24 Billion EUR | -9.09% |
| 2012 | 1.37 Billion EUR | -0.83% |
| 2011 | 1.38 Billion EUR | 3.37% |
| 2010 | 1.34 Billion EUR | -10.17% |
| 2009 | 1.49 Billion EUR | 31.21% |
| 2008 | 1.13 Billion EUR | 0.45% |
| 2007 | 1.13 Billion EUR | 3.26% |
| 2006 | 1.09 Billion EUR | -14.26% |
| 2005 | 1.27 Billion EUR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 1.59 Billion EUR | -13.67% |
| 2024 Q2 | 1.58 Billion EUR | -0.34% |
| 2023 Q4 | 1.84 Billion EUR | 14.06% |
| 2023 Q3 | 1.61 Billion EUR | -0.96% |
| 2023 Q2 | 1.63 Billion EUR | -2.42% |
| 2023 FY | 1.84 Billion EUR | 3.36% |
| 2023 Q1 | 1.67 Billion EUR | -6.23% |
| 2022 Q1 | 1.87 Billion EUR | -2.43% |
| 2022 FY | 1.78 Billion EUR | -6.81% |
| 2022 Q4 | 1.78 Billion EUR | 8.01% |
| 2022 Q3 | 1.65 Billion EUR | 1.66% |
| 2022 Q2 | 1.62 Billion EUR | -13.01% |
| 2021 Q1 | 2.02 Billion EUR | -10.67% |
| 2021 FY | 1.91 Billion EUR | -15.6% |
| 2021 Q2 | 1.95 Billion EUR | -3.65% |
| 2021 Q3 | 1.9 Billion EUR | -2.74% |
| 2021 Q4 | 1.91 Billion EUR | 0.83% |
| 2020 FY | 2.27 Billion EUR | 52.03% |
| 2020 Q4 | 2.27 Billion EUR | 8.78% |
| 2020 Q1 | 1.82 Billion EUR | 22.31% |
| 2020 Q2 | 2.02 Billion EUR | 11.02% |
| 2020 Q3 | 2.08 Billion EUR | 2.92% |
| 2019 Q4 | 1.49 Billion EUR | -2.44% |
| 2019 Q1 | 1.41 Billion EUR | 6.58% |
| 2019 Q2 | 1.43 Billion EUR | 1.21% |
| 2019 FY | 1.49 Billion EUR | 12.41% |
| 2019 Q3 | 1.53 Billion EUR | 6.81% |
| 2018 Q3 | 1.26 Billion EUR | -0.98% |
| 2018 FY | 1.32 Billion EUR | 3.39% |
| 2018 Q2 | 1.27 Billion EUR | 1.18% |
| 2018 Q1 | 1.25 Billion EUR | -2.18% |
| 2018 Q4 | 1.32 Billion EUR | 5.48% |
| 2017 Q4 | 1.28 Billion EUR | 4.45% |
| 2017 FY | 1.28 Billion EUR | -1.74% |
| 2017 Q3 | 1.23 Billion EUR | 2.98% |
| 2017 Q2 | 1.19 Billion EUR | -4.51% |
| 2017 Q1 | 1.25 Billion EUR | -4.34% |
| 2016 FY | 1.3 Billion EUR | -4.15% |
| 2016 Q1 | 1.34 Billion EUR | -1.45% |
| 2016 Q3 | 1.37 Billion EUR | 0.69% |
| 2016 Q2 | 1.36 Billion EUR | 1.71% |
| 2016 Q4 | 1.3 Billion EUR | -5.02% |
| 2015 Q2 | 1.32 Billion EUR | -5.69% |
| 2015 Q1 | 1.4 Billion EUR | 5.24% |
| 2015 FY | 1.36 Billion EUR | 2.09% |
| 2015 Q4 | 1.36 Billion EUR | 3.19% |
| 2015 Q3 | 1.32 Billion EUR | -0.32% |
| 2014 Q2 | 1.19 Billion EUR | -0.87% |
| 2014 Q4 | 1.33 Billion EUR | 5.55% |
| 2014 Q3 | 1.26 Billion EUR | 5.65% |
| 2014 Q1 | 1.2 Billion EUR | -3.13% |
| 2014 FY | 1.33 Billion EUR | 7.08% |
| 2013 FY | 1.24 Billion EUR | -9.09% |
| 2013 Q4 | 1.24 Billion EUR | -0.18% |
| 2013 Q3 | 1.25 Billion EUR | 1.02% |
| 2013 Q2 | 1.23 Billion EUR | -7.6% |
| 2013 Q1 | 1.34 Billion EUR | -2.44% |
| 2012 Q4 | 1.37 Billion EUR | -2.83% |
| 2012 Q1 | 1.35 Billion EUR | -1.9% |
| 2012 Q2 | 1.34 Billion EUR | -1.33% |
| 2012 FY | 1.37 Billion EUR | -0.83% |
| 2012 Q3 | 1.41 Billion EUR | 5.44% |
| 2011 Q2 | 1.24 Billion EUR | -5.01% |
| 2011 Q1 | 1.3 Billion EUR | -2.3% |
| 2011 Q3 | 1.26 Billion EUR | 1.61% |
| 2011 Q4 | 1.38 Billion EUR | 9.62% |
| 2011 FY | 1.38 Billion EUR | 3.37% |
| 2010 Q1 | 1.53 Billion EUR | 3.13% |
| 2010 FY | 1.34 Billion EUR | -10.17% |
| 2010 Q4 | 1.34 Billion EUR | 6.82% |
| 2010 Q3 | 1.25 Billion EUR | -9.98% |
| 2010 Q2 | 1.39 Billion EUR | -9.42% |
| 2009 Q4 | 1.49 Billion EUR | 0.0% |
| 2009 FY | 1.49 Billion EUR | 31.21% |
| 2008 FY | 1.13 Billion EUR | 0.45% |
| 2007 FY | 1.13 Billion EUR | 3.26% |
| 2006 FY | 1.09 Billion EUR | -14.26% |
| 2005 FY | 1.27 Billion EUR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Cegedim SA | 629.51 Million EUR | -193.422% |
| Guerbet SA | 646.97 Million EUR | -185.504% |
| Nexus AG | 153.13 Million EUR | -1106.217% |
| Bastide Le Confort Médical SA | 566.34 Million EUR | -226.151% |
| Revenio Group Oyj | 37.6 Million EUR | -4812.574% |
| Sartorius Aktiengesellschaft | 6.99 Billion EUR | 73.605% |
| LNA Santé SA | 1.19 Billion EUR | -54.105% |
| Siemens Healthineers AG | 28.55 Billion EUR | 93.53% |
| Medios AG | 125.94 Million EUR | -1366.603% |
| Equasens Société anonyme | 166.41 Million EUR | -1009.926% |
| Stratec SE | 246.2 Million EUR | -650.24% |